MedTrace Logo

Hexoskin Medical System - ECG Performance Testing

NCT05970328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-08-21

No results posted yet for this study

Summary

The goal of this observational study is to validate the efficacy of the Hexoskin Medical System (HMS) for its intended use (i.e., manual assessment of cardiac rhythm disturbances) in non-critical adult participants who are suspected of having an arrhythmia or have evidence of arrhythmia requiring monitoring via 24-hour Holter monitor.

Conditions

  • Cardiac Rhythm Disturbance

Interventions

DEVICE

Hexoskin Medical System

Participant wears both the Hexoskin Medical System and the Nasiff Holter Monitor at the same time to acquire ECG recordings.

Sponsors & Collaborators

  • Carré Technologies Inc.

    lead INDUSTRY

Principal Investigators

  • Christopher Cheung, MD · Sunnybrook Health Sciences Centre

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2024-02-17
Completion
2024-02-17

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970328 on ClinicalTrials.gov